MENLO PARK, Calif. , May 06, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2020 . As previously announced, in January 2020 , we and Illumina mutually agreed to terminate the Agreement and Plan

MENLO PARK, Calif. , April 27, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its First Quarter 2020 Financial Results on Wednesday, May 6, 2020 , at 4:30pm Eastern Time .

Deployment expands access to PacBio’s highly accurate long reads on the African continent for a variety of applications, from ethnic-specific reference genomes to COVID-19 research MENLO PARK, Calif. and PRETORIA, South Africa , April 20, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California,

LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19 MENLO PARK, Calif.

MENLO PARK, Calif. , March 18, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not

MENLO PARK, Calif. , March 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that industry veteran Christian Henry has been appointed to serve as Chairman of

Company will sponsor sequencing and assembly at UC Davis to produce reference-grade genomes for several ecologically important organisms in the state of California MENLO PARK, Calif. and DAVIS, Calif. , Feb. 25, 2020 (GLOBE NEWSWIRE) -- The Earth BioGenome Project (EBP) and Pacific Biosciences of

Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development MENLO PARK, Calif. , Feb. 07, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael

Annual Revenue Increase of 16% Year Over Year MENLO PARK, Calif. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its fourth quarter and year ended December 31, 2019 , as attached.

MENLO PARK, Calif. , Jan. 21, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Pacific Biosciences of California, Inc. (NASDAQ: PACB), please note that the date in paragraph three should read February 6, 2020 , not January 6, 2020 , as previously stated.